Q2 2016 Holdings
Filed 2016-08-15 | 135 holdings | $2.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AbbVie Inc.(ABBV) | COM | 00287Y109 | $889.9M | 14,373,538 | 39.0% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $795.8M | 24,516,738 | 34.9% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $373.9M | 4,806,483 | 16.4% |
| Cerus Corporation(CERS) | COM | 157085101 | $84.6M | 13,553,275 | 3.7% |
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $57.0M | 1,912,680 | 2.5% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $42.6M | 15,010,534 | 1.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $9.9M | 745,521 | 0.4% |
| Agios Pharmaceuticals, Inc.(AGIO) | COM | 00847X104 | $8.7M | 207,915 | 0.4% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | COM | 04280A100 | $5.4M | 1,009,509 | 0.2% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $3.6M | 5,122,153 | 0.2% |
| Incyte Corporation(INCY) | COM | 45337C102 | $1.9M | 23,498,697 | 0.1% |
| Seattle Genetics, Inc. | COM | 812578102 | $1.7M | 43,238,967 | 0.1% |
| Cellectis S.A.(CLLS) | SPONSORED ADS | 15117K103 | $1.3M | 50,000 | 0.1% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $815.0K | 100,000 | 0.0% |
| Aldeyra Therapeutics, Inc.(ALDX) | COM | 01438T106 | $808.0K | 142,000 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $764.0K | 6,543,295 | 0.0% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | COM | 02043Q107 | $629.0K | 11,340 | 0.0% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $628.0K | 180,582 | 0.0% |
| Incyte Corporation Notes 1.25% 11/15/2020 144A | NOTE 1.25% 11/15/2020 | 45337CAL6 | $467.3K | $274,500,000 | 0.0% |
| Incyte Corporation Notes 0.375% 11/15/2018 144A | NOTE 0.375% 11/15/2018 | 45337CAK8 | $431.8K | $259,000,000 | 0.0% |
| Genomic Health, Inc.(GHDX) | COM | 37244C101 | $354.0K | 13,668,866 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $179.7K | 5,509,560 | 0.0% |
| XenoPort, Inc. Notes 2.5% 2/1/2022 | NOTE 2.5% 2/1/2022 | 98411CAB6 | $98.5K | $100,000,000 | 0.0% |
| Acorda Therapeutics, Inc. | COM | 00484M106 | $93.4K | 3,661,082 | 0.0% |
| BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 | NOTE 1.875% 4/23/2017 | 09061GAD3 | $84.9K | $22,379,000 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $67.4K | 1,318,341 | 0.0% |
| Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 | NOTE 1.75% 6/15/2021 | 00484MAA4 | $67.4K | $77,083,000 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $63.1K | 4,865,647 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $51.6K | 2,857,250 | 0.0% |
| Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | $51.3K | 7,752,487 | 0.0% |
| Clovis Oncology, Inc. 2.5% 9/15/2021 | NOTE 2.5% 9/15/2021 | 189464AB6 | $51.3K | $72,758,000 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $48.4K | 6,554,967 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $40.7K | 895,422 | 0.0% |
| Versartis, Inc. | COM | 92529L102 | $30.1K | 2,723,399 | 0.0% |
| Exelixis, Inc. Notes 4.25% 8/15/2019 | NOTE 4.25% 8/15/2019 | 30161QAC8 | $29.7K | $20,000,000 | 0.0% |
| Advanced Accelerator Applications S.A. | SPONSORED ADR | 00790T100 | $25.2K | 833,089 | 0.0% |
| XenoPort, Inc. | COM | 98411C100 | $24.5K | 3,475,672 | 0.0% |
| Intra-Cellular Therapies, Inc.(ITCIEUR) | COM | 46116X101 | $23.6K | 609,166 | 0.0% |
| Sangamo BioSciences, Inc.(SGMO) | COM | 800677106 | $23.5K | 4,055,876 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | COM | 45826J105 | $22.7K | 1,062,120 | 0.0% |
| Exelixis, Inc.(EXEL) | COM | 30161Q104 | $20.2K | 2,580,000 | 0.0% |
| Medivation, Inc. | COM | 58501N101 | $19.9K | 329,876 | 0.0% |
| Achillion Pharmaceuticals, Inc.(ACHNEUR) | COM | 00448Q201 | $19.3K | 2,475,515 | 0.0% |
| Novavax, Inc. | COM | 670002104 | $17.3K | 2,379,254 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $16.8K | 3,970,250 | 0.0% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $16.6K | 872,072 | 0.0% |
| Halozyme Therapeutics, Inc.(HALO) | COM | 40637H109 | $15.9K | 1,838,057 | 0.0% |
| Array BioPharma Inc.(ARRYEUR) | COM | 04269X105 | $15.3K | 4,310,666 | 0.0% |
| Corsicanto Ltd. 3.5% 1/15/2032 | NOTE 3.5% 1/15/2032 | 220480AB3 | $15.3K | $15,000,000 | 0.0% |
| Aegerion Pharmaceuticals, Inc. Notes 2.0% 8/15/2019 | NOTE 2.0% 8/15/2019 | 00767EAB8 | $14.8K | $26,517,000 | 0.0% |